CH-3011 Bern T + 41 31 310 99 60
F + 41 31 310 99 61
The project in brief
A multitude of diseases have genetic causes, and genetic factors also affect the way in which drugs work. The corresponding knowledge makes it possible to develop new drugs enabling more targeted therapies, in the sense of «personalised medicine», and presumably having fewer side-effects. The TA-SWISS study examines the opportunities and risks of genome-based medicine.
Timetable: project completed (2004)
Project mandatary: Dr. Klaus Peter Rippe, Ethik im Diskurs GmbH, Zurich